Gujarat Inject invalidates physical shares after 10:1 split

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Physical share certificates are now invalid following the 10:1 sub-division
  • Post-split shares must be credited to demat accounts per SEBI Regulation 39(2A)
  • Shareholders must submit Form ISR-4 and valid KYC documents to Bigshare Services
  • Existing physical certificates cannot be used for transfer or transmission
powered bylight_fuzz_icon
51863760

*this image is generated using AI for illustrative purposes only.

Gujarat Inject (Kerala) Limited has declared all existing physical share certificates invalid with immediate effect. This action follows the completion of the company's equity share sub-division, where each share of face value ₹10 was split into 10 shares of face value ₹1.

The move is mandated under Regulation 39(2A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation requires that securities arising from corporate actions such as stock splits be issued exclusively in dematerialized form. Consequently, physical certificates can no longer be used for transfer, transmission, or other corporate purposes.

Claiming Post-Split Entitlement

Shareholders holding physical certificates must now complete a specific process to claim their post-split shares and have them credited to their demat accounts. The company has outlined the necessary steps and documentation required to facilitate this transition.

Required Documentation

To process the claim, shareholders must submit the following documents to the Registrar and Share Transfer Agent (RTA), Bigshare Services Private Limited:

  • Duly filled and signed Claim Form for release of shares.
  • Form ISR-4, completed and signed by all joint holders if applicable.
  • Self-attested photocopy of the existing (now invalid) physical share certificate(s).
  • Self-attested copy of PAN Card for all shareholder(s).
  • Self-attested copy of address proof (Aadhaar Card, Voter ID, Passport, or utility bill not older than 3 months).
  • Original cancelled cheque leaf or bank passbook/statement showing name, account number, and IFSC code.
  • Client Master List (CML) or Client Master Report of the demat account, attested by the Depository Participant (DP).
  • Signature attestation by the bank as per Form ISR-2 format.
  • Updated PAN/KYC/bank details registered using Form ISR-1, where required.
  • Authorization/consent letter from all joint holders, in case of joint holdings.
  • Succession Certificate, Legal Heir Certificate, or Transmission Form, in case of deceased shareholders.

Submission Process

Shareholders who do not currently hold a demat account must first open one with a DP registered with NSDL or CDSL. Once the account is active, they must obtain the Client Master List from their DP.

The complete set of documents must be submitted to the RTA at the following address:

Bigshare Services Pvt. Ltd. Office No 303, Sun Square Complex, Near Chakradhari Society Bus Stop, Girish Cold Drinks Cross Road, C.G. Road, Navrangpura, Ahmedabad-380009

Alternatively, submissions may be made through modes specified on the company's website. The company urges shareholders to complete this process at the earliest to ensure timely credit of entitlements.

What the Numbers Show

The sub-division ratio of 10:1 implies that for every single physical certificate held, the shareholder is entitled to ten new electronic shares. While the total value of the holding remains unchanged, the liquidity and tradability of the shares are enhanced by the lower face value. The strict requirement for demat conversion highlights the regulatory push towards eliminating paper-based ownership risks in Indian capital markets.

Historical Stock Returns for Gujarat Inject Kerala

1 Day5 Days1 Month6 Months1 Year5 Years
+2.59%+0.85%-16.27%+30.41%+376.00%+3,866.67%

How might the mandatory dematerialization of Gujarat Inject's shares impact trading volumes and liquidity for retail investors in the near term?

What are the potential compliance risks or penalties for shareholders who fail to convert their physical certificates within the stipulated timeline?

Could this regulatory enforcement signal a broader acceleration in SEBI's push to eliminate physical share certificates across the Indian equity market?

like16
dislike

Gujarat Inject Kerala files FY26 annual report with BSE

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Gujarat Inject Kerala Ltd filed its FY26 annual report with BSE on September 7, 2026
  • Filing made pursuant to Regulation 34 of SEBI LODR Regulations, 2015
  • Hardikkumar Anilbhai Radadiya appointed CFO effective August 10, 2026
  • Murli Shivshankaran Nair continues as Chairman and Whole-time Director
powered bylight_fuzz_icon
50359164

*this image is generated using AI for illustrative purposes only.

Gujarat Inject (Kerala) Ltd has filed its annual report for the financial year 2025-26 with the Bombay Stock Exchange. The submission, dated September 7, 2026, complies with SEBI listing regulations and provides an update on the company’s corporate governance structure.

The filing serves as a formal intimation under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The complete document is available on the company’s official website for investor review.

Board Composition Updates

The annual report details changes in the Board of Directors and Key Managerial Personnel as of March 31, 2026, and subsequent updates.

Murli Shivshankaran Nair continues to serve as Chairman and Whole-time Director. The board includes Non-Executive Independent Directors Rushiraj Zaverbhai Patel, Nileshbhai Vinubhai Rangholiya, and Deepak Diwan Bachwani. Ila Sunil Trivedi is listed as an Additional Non-Executive Independent Director.

Key Personnel Changes

Hardikkumar Anilbhai Radadiya assumed the role of Chief Financial Officer effective August 10, 2026, succeeding Murli Nair. Manmeetkaur Harshdeepsingh Bhatia remains the Company Secretary and Compliance Officer, a position she has held since June 10, 2024.

Committee Structure

The Audit Committee is chaired by Rushiraj Zaverbhai Patel, with Murli Shivshankaran Nair and Nileshbhai Vinubhai Rangholiya serving as members. The Nomination & Remuneration Committee is also chaired by Rushiraj Zaverbhai Patel, comprising Nileshbhai Vinubhai Rangholiya and Deepak Diwan Bachwani as members.

Historical Stock Returns for Gujarat Inject Kerala

1 Day5 Days1 Month6 Months1 Year5 Years
+2.59%+0.85%-16.27%+30.41%+376.00%+3,866.67%

How might the transition of CFO duties from the Chairman to Hardikkumar Radadiya impact Gujarat Inject's financial strategy and operational oversight?

What are the expected implications of Ila Sunil Trivedi's appointment as an Additional Non-Executive Independent Director on the board's decision-making dynamics?

How will the new leadership structure influence Gujarat Inject's compliance posture and risk management in the coming fiscal year?

like20
dislike

More News on Gujarat Inject Kerala

1 Year Returns:+376.00%